|
Pseudonym
|
Gender
|
Age range
|
Group allocation
|
|---|
|
Moderate risk of developing type 2 diabetesa
|
|
Alice
|
Female
|
61–65
|
Group 3b
|
|
Anne
|
Female
|
46–50
|
Group 3
|
|
Arthur
|
Male
|
51–55
|
Group 2c
|
|
Charles
|
Male
|
51–55
|
Group 1d
|
|
Ellie
|
Female
|
46–50
|
Group 3
|
|
Evie
|
Female
|
51–55
|
Group 3
|
|
George
|
Male
|
56–60
|
Group 2
|
|
Isabelle
|
Female
|
66–70
|
Group 1
|
|
Jane
|
Female
|
36–40
|
Group 1
|
|
Jennifer
|
Female
|
56–60
|
Group 3
|
|
Joseph
|
Male
|
56–60
|
Group 3
|
|
Leah
|
Female
|
51–55
|
Group 2
|
|
Lily
|
Female
|
61–65
|
Group 3
|
|
Lucas
|
Male
|
51–55
|
Group 3
|
|
Lucy
|
Female
|
46–50
|
Group 2
|
|
Phoebe
|
Female
|
61–65
|
Group 2
|
|
Rosie
|
Female
|
41–45
|
Group 2
|
|
Sarah
|
Female
|
46–50
|
Group 3
|
|
Sophie
|
Female
|
61–65
|
Group 3
|
|
Steven
|
Male
|
61–65
|
Group 2
|
|
Theo
|
Male
|
61–65
|
Group 1
|
|
Thomas
|
Male
|
66–70
|
Group 1
|
|
High risk of developing type 2 diabetese
|
|
Emily
|
Female
|
56–60
|
Group 2
|
|
Emma
|
Female
|
61–65
|
Group 3
|
|
Henry
|
Male
|
51–55
|
Group 1
|
|
Noah
|
Male
|
71–75
|
Group 1
|
- aModerate risk defined as a score of 16–24 points
- bGroup 3 could access feedback from both the glucose sensor and activity monitor for all of the six weeks;
- cGroup 2: participants could access feedback from the activity monitor for all of the six weeks but were also able to access feedback from the glucose sensor in the final two weeks;
- dGroup 1: participants could access feedback from the glucose sensor for all of the six weeks but were also able to access feedback from the activity monitor in the final two weeks
- eHigh risk defined as a score of 25–47 points
